AliAFarooquiMD

PubMed

• 1 citations
  National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder.
  Mark J Niciu, Robert C Meisner, Brent R Carr, Ali A Farooqui, David Feifel, Adam Kaplin, E Jeremy Kendrick, Paul M Kim, Christopher D Schneck, Jennifer L Vande Voort, ...> ;Journal of Affective Disorders. 2024 Feb 1
• Use of botulinum toxin A for depression symptoms in patients with treatment-resistant bipolar illness: A case series.
  Ali A Farooqui, Jessica M Fulkerson, Rif S El-Mallakh> ;Bipolar Disorders. 2023 Dec 1
• No NLRP3 Inflammasome Expression in the Ouabain Animal Model of Bipolar Disorder.
  Ali A Farooqui, Yonglin Gao, Megan A Coghlan, Rifaat S El-Mallakh> ;Cureus. 2022 May 1
• 7 citations
  Effects of somatic treatments on suicidal ideation and completed suicides
  Elise M Hawkins, William Coryell, Stephen Leung, Sagar V. Parikh, Cody Weston, Paul S. Nestadt, John I. Nurnberger, Adam I. Kaplin, Anupama Kumar, Ali A. Farooqui, Rif...> ;Brain and Behavior. 2021 Oct 17
• 4 citations
  Early use of telepsychotherapy in resident continuity clinics-our experience and a review of literature.
  Svetlana Famina, Ali A. Farooqui, Robert Caudill> ;Mhealth. 2020 Jan 5
• Join now to see all